FDA May Grant Full Approval For Pfizer Jab As Early As September

The Food and Drug Administration (FDA) may grant full approval for Pfizer’s Covid-19 vaccination as early as September or October, according to the Wall Street Journal, citing FDA advisers and former officials familiar with the process.

The rush for full approval – as opposed to the current emergency use authorization – comes as many schools, hospitals and employers have used full approval as a benchmark for moving forward with mandatory vaccinations.

We are primarily funded by readers. Please subscribe and donate to support us!

We’d like to see it approved as fast as humanly possible, so we can really go back to just the more normal experience,” said Jim Malatras, chancellor of the State University of New York system, who currently cannot impose a vaccine mandate for some 400,000 students served under the system. At present, the school requires either vaccines or weekly testing.



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.